To the IMSMP Family and Supporters of the Tisch MS Research Center of New York, It gives me great pride and joy to announce that the FDA has approved our Phase I clinical trial for the use of bone marrow-derived neural stem cells in the treatment of multiple sclerosis. This exciting development is the culmination of a decade long effort by the dedicated team of scientists at the Tisch MS Research Center of New York at a cost of several million dollars. In treating patients with MS,...
more- Services
- Team
- Patient Education
- Diagnosing MS
- Understanding Some Basics About MS
- Relapsing Remitting MS
- Secondary Progressive MS
- Primary Progressive MS
- Preparing for Your New Patient Visit
- Preparing for a Spinal Tap
- Injection & Medication Counseling
- Relapse vs. Pseudorelapse
- Neuromyelitis Optics vs. Multiple Sclerosis
- Resources
- FAQ
- Research
- News
- Contact
- Leave a Review